The stock market had a mixed day as we head into a long holiday weekend and the end of a busy spring break. The$NASDAQ(NASDAQ.US)$and$SPDR S&P 500 ETF(SPY.US)$both dropped a bit, while the$iシェアーズ ラッセル 2000 ETF(IWM.US)$, which tracks smaller companies, saw some gains but didn't keep up its momentum throughout the day. Interestingly, the Russell 2000's rally earlier in the day helped the Nasdaq see more stocks reaching new highs, but this excitement cooled off mid...
Braze's high P/S ratio is justified by robust revenue growth and future expectations. Investors anticipate strong future growth, keeping the share price buoyant.
Insiders at Braze offloading shares, including a notable sale by Kenneth Lawler, might concern shareholders. Still, high insider ownership suggests solid alignment between executives and shareholders. However, the lack of insider buying coupled with continuous selling might alarm investors.
The results indicated Braze's positive stance and revenue overachievement, despite a deceleration in customer growth and drop in net revenue retention. This led to a 2.5% stock price rise. However, valuation and business qualities should also be considered for investments.
$ブレイズ(BRZE.US)$ Braze shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q2 and FY23 EPS and sales guidance above analyst estimates. $カイバル ブランズ イノベーションズ グループ(KAVL.US)$ Kaival Brands shares are trading higher after the company reached an agreement with Phillip Morris for international electronic nicotine delivery system product distribution. $ソレノ セラピーティクス(SLNO.US)$ Soleno Therapeutics shares are trading higher...
ブレイズに関するコメント
In reaction to earnings/guidance:
• $プラネット ラボズ(PL.US)$ +11.3%, $コアメイン A(CNM.US)$ +6.1%, $リーガル レックスノード(RRX.US)$ +2% (reaffirms outlook), $オラクル(ORCL.US)$ +1.6%
Other news:
• $アケロ セラピューティクス(AKRO.US)$ +93.2% (reports Phase 2b HARMONY Study)
• $Akouos(AKUS.US)$ +10.3% (FDA clears IND application to initiate a Phase 1/2 first in human pediatric clinical trial of AK-OTOF)
• $カタリスト ファーマシューティカルズ(CPRX.US)$ +7.7...
• $Blackstone Secured Lending Fund(BXSL.US)$ : Compass Point Upgrades to Buy from Neutral - PT $25.50 (from $26.25)
• $DCP Midstream(DCP.US)$ : RBC Upgrades to Outperform from Sector Perform - PT $40 (from $37)
• $ハーバライフ(HLF.US)$ : Jefferies Upgrades to Buy from Hold - PT $26
• $JPモルガン チェース(JPM.US)$ : Citigroup Upgrades to Buy from Neutral - PT $135 (from $145)
• $ナイトスイフトトランスポーテーション(KNX.US)$ : Evercore ISI Upgrades to Ou...
Braze shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q2 and FY23 EPS and sales guidance above analyst estimates.
$カイバル ブランズ イノベーションズ グループ(KAVL.US)$
Kaival Brands shares are trading higher after the company reached an agreement with Phillip Morris for international electronic nicotine delivery system product distribution.
$ソレノ セラピーティクス(SLNO.US)$
Soleno Therapeutics shares are trading higher...
まだコメントはありません